Topics
September 2021 | 5 Questions
5Q with Matias Iglicki, MD, PHD
Matias Iglicki, MD, PHD
July/August 2021 | 5 Questions
5Q with Aaron Nagiel, MD, PHD
Aaron Nagiel, MD, PhD
May/June 2021 | 5 Questions
5Q with Netan Choudhry, MD, FRCSC
Netan Choudhry, MD, FRCSC
October 2013 | 5 Questions
Thomas Albini, MD
Dr. Albini is an Associate Professor of Clinical Ophthalmology at Bascom Palmer Eye Institute in Miami and a member of the Retina Today Editorial Board.
September 2013 | 5 Questions
John W. Kitchens, MD
Dr. Kitchens is a vitreoretinal surgeon with Retina Associates of Kentucky in Lexington and a member of the Retina Today Editorial Board.
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
